Opendata, web and dolomites

HG

Real-time molecular diagnostic testing for human infectious diseases using LAMP (Loop Mediated Isothermal Amplification) technology.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "HG" data sheet

The following table provides information about the project.

Coordinator
HIBERGENE DIAGNOSTICS LIMITED 

Organization address
address: 21 PALMERSTOWN GARDENS - RATHMINES
city: DUBLIN
postcode: DUBLIN 6
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.hibergene.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-02-01   to  2016-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HIBERGENE DIAGNOSTICS LIMITED IE (DUBLIN) coordinator 50˙000.00

Map

 Project objective

Roughly 85% of small & medium sized hospitals remain without molecular diagnostics capabilities for human infectious diseases. Current solutions are expensive or have complex workflows and therefore have been unable to penetrate this large market segment. This is a key issue resulting in a more costly healthcare system and reducing efficiency when such testing must be carried out offsite rather than in-house. As accurate diagnostic results take longer to produce this can have a major negative impact on a patient’s health, particularly when urgent diagnosis and appropriate care may be required. The in vitro HG diagnostics system, consisting of the portable testing device (HG Swift) as well as freeze dried reagents, is cost-effective and makes molecular diagnostics accessible to a laboratory or near patient environment such as an A&E or maternity labour ward with minimal training required. Furthermore the HG system is unique, producing highly accurate and rapid results (less than 60 minutes “sample to result”) and is flexible, capable of testing for multiple human infectious diseases. Once the HG solution has been commercialised, Hibergene can address the unmet needs of the large unmet market segment of small to medium sized hospitals by improving patient diagnosis and helping to create a more efficient healthcare system overall.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

SBR (2020)

SMART BONE REGENERATION

Read More